Radionetics Oncology
Latest round
- Series A
Last raised
- Aug 2023
Total raised
- $108M
Investors
- 5
About Radionetics Oncology
Radionetics Oncology, Inc.Founded in 2021 in Menlo Park, US, Radionetics Oncology specializes in precision oncology medications. The company was established by R Struthers, who has a notable background in the biotech sector.Radionetics specializes in developing targeted small molecule radiopharmaceuticals, which utilize a precise methodology to deliver radiation directly to cancerous tumors while minimizing damage to healthy tissues.Radionetics operates a revenue model based on partnerships with major pharmaceutical companies, including a strategic agreement with Lilly, which featured a USD 140 mn upfront payment and an option for Lilly to acquire Radionetics for USD 1 bn. The company is focused on launching new therapeutics targeting additional cancer types and plans to extend its market presence into Europe and Asia by 2025.
Who invested in Radionetics Oncology
5 investors across 2 rounds
See all investors in Radionetics Oncology
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Radionetics Oncology
Who invested in Radionetics Oncology?
Radionetics Oncology has 5 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Radionetics Oncology raised?
Radionetics Oncology has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Radionetics Oncology last raise money?
Radionetics Oncology's most recent round on record is a Series A, in Aug 2023.
What does Radionetics Oncology do?
Radionetics Oncology is a pharmaceuticals company.
Where is Radionetics Oncology headquartered?
Radionetics Oncology is headquartered in Menlo Park, US.
Which VCs invest in companies like Radionetics Oncology?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Radionetics Oncology's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like Radionetics Oncology? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.